-
1
-
-
79961108629
-
Reduced lung-cancer mortality with low-dose computed tomographic screening
-
National Lung Screening Trial Research Team D.R. Aberle, and A.M. Adams Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409 10.1056/NEJMoa1102873
-
(2011)
N Engl J Med
, vol.365
, pp. 395-409
-
-
Aberle, D.R.1
Adams, A.M.2
-
2
-
-
84907591805
-
Lung cancer screening beyond low-dose computed tomography: The role of novel biomarkers
-
N. Hasan, R. Kumar, and M.S. Kavuru Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers Lung 2014 639 648 10.1007/s00408-014-9636-z
-
(2014)
Lung
, pp. 639-648
-
-
Hasan, N.1
Kumar, R.2
Kavuru, M.S.3
-
3
-
-
84886290631
-
The impact of genomic changes on treatment of lung cancer
-
S. Cardarella, and B.E. Johnson The impact of genomic changes on treatment of lung cancer Am J Respir Crit Care Med 188 2013 770 775 10.1164/rccm.201305-0843PP
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 770-775
-
-
Cardarella, S.1
Johnson, B.E.2
-
4
-
-
0027751663
-
The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
-
0092-8674(93)90529-Y [pii]
-
R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854 doi:0092-8674(93)90529-Y [pii]
-
(1993)
Cell
, vol.75
, pp. 843-854
-
-
Lee, R.C.1
Feinbaum, R.L.2
Ambros, V.3
-
5
-
-
0034597777
-
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
-
A.E. Pasquinelli, B.J. Reinhart, and F. Slack Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA Nature 408 2000 86 89 10.1038/35040556
-
(2000)
Nature
, vol.408
, pp. 86-89
-
-
Pasquinelli, A.E.1
Reinhart, B.J.2
Slack, F.3
-
6
-
-
20444460289
-
MicroRNA expression profiles classify human cancers
-
nature03702 [pii]
-
J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 doi:nature03702 [pii]
-
(2005)
Nature
, vol.435
, pp. 834-838
-
-
Lu, J.1
Getz, G.2
Miska, E.A.3
-
7
-
-
8144225486
-
MicroRNA genes are transcribed by RNA polymerase II
-
Y. Lee, M. Kim, and J. Han MicroRNA genes are transcribed by RNA polymerase II EMBO J 23 2004 4051 4060 10.1038/sj.emboj.7600385
-
(2004)
EMBO J
, vol.23
, pp. 4051-4060
-
-
Lee, Y.1
Kim, M.2
Han, J.3
-
8
-
-
10644234841
-
The drosha-DGCR8 complex in primary microRNA processing
-
gad.1262504 [pii]
-
J. Han, Y. Lee, K.H. Yeom, Y.K. Kim, H. Jin, and V.N. Kim The drosha-DGCR8 complex in primary microRNA processing Genes Dev 18 2004 3016 3027 doi:gad.1262504 [pii]
-
(2004)
Genes Dev
, vol.18
, pp. 3016-3027
-
-
Han, J.1
Lee, Y.2
Yeom, K.H.3
Kim, Y.K.4
Jin, H.5
Kim, V.N.6
-
9
-
-
9344235449
-
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs
-
rna.7135204 [pii]
-
X. Cai, C.H. Hagedorn, and B.R. Cullen Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs RNA 10 2004 1957 1966 doi:rna.7135204 [pii]
-
(2004)
RNA
, vol.10
, pp. 1957-1966
-
-
Cai, X.1
Hagedorn, C.H.2
Cullen, B.R.3
-
10
-
-
67749129007
-
DICER1 mutations in familial pleuropulmonary blastoma
-
D.A. Hill, J. Ivanovich, and J.R. Priest DICER1 mutations in familial pleuropulmonary blastoma Science 325 2009 965 10.1126/science.1174334
-
(2009)
Science
, vol.325
, pp. 965
-
-
Hill, D.A.1
Ivanovich, J.2
Priest, J.R.3
-
11
-
-
20144373433
-
Reduced expression of dicer associated with poor prognosis in lung cancer patients
-
Y. Karube, H. Tanaka, and H. Osada Reduced expression of dicer associated with poor prognosis in lung cancer patients Cancer Sci 96 2005 111 115 10.1111/j.1349-7006.2005.00015.x
-
(2005)
Cancer Sci
, vol.96
, pp. 111-115
-
-
Karube, Y.1
Tanaka, H.2
Osada, H.3
-
12
-
-
33644819964
-
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
-
S1535-6108(06)00033-X[pii]
-
N. Yanaihara, N. Caplen, and E. Bowman Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198 doi:S1535-6108(06)00033-X[pii]
-
(2006)
Cancer Cell
, vol.9
, pp. 189-198
-
-
Yanaihara, N.1
Caplen, N.2
Bowman, E.3
-
13
-
-
33144490646
-
A microRNA expression signature of human solid tumors defines cancer gene targets
-
0510565103 [pii]
-
S. Volinia, G.A. Calin, and C.G. Liu A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261 doi:0510565103 [pii]
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.G.3
-
14
-
-
48749122914
-
Circulating microRNAs as stable blood-based markers for cancer detection
-
P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518 10.1073/pnas.0804549105
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 10513-10518
-
-
Mitchell, P.S.1
Parkin, R.K.2
Kroh, E.M.3
-
16
-
-
84865063456
-
Classification of the four main types of lung cancer using a microRNA-based diagnostic assay
-
S. Gilad, G. Lithwick-Yanai, and I. Barshack Classification of the four main types of lung cancer using a microRNA-based diagnostic assay J Mol Diagn 14 2012 510 517 10.1016/j.jmoldx.2012.03.004
-
(2012)
J Mol Diagn
, vol.14
, pp. 510-517
-
-
Gilad, S.1
Lithwick-Yanai, G.2
Barshack, I.3
-
17
-
-
2542626605
-
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
-
J. Takamizawa, H. Konishi, and K. Yanagisawa Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 2004 3753 3756 10.1158/0008-5472.CAN-04-0637
-
(2004)
Cancer Res
, vol.64
, pp. 3753-3756
-
-
Takamizawa, J.1
Konishi, H.2
Yanagisawa, K.3
-
18
-
-
74549118209
-
Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach
-
J.A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D.P. Clark, and W.H. Westra Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach Clin Cancer Res 16 2010 610 619 10.1158/1078-0432.CCR-09-2638
-
(2010)
Clin Cancer Res
, vol.16
, pp. 610-619
-
-
Bishop, J.A.1
Benjamin, H.2
Cholakh, H.3
Chajut, A.4
Clark, D.P.5
Westra, W.H.6
-
19
-
-
84879983640
-
Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma
-
J. Hamamoto, K. Soejima, and S. Yoda Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma Mol Med Rep 8 2013 456 462 10.3892/mmr.2013.1517
-
(2013)
Mol Med Rep
, vol.8
, pp. 456-462
-
-
Hamamoto, J.1
Soejima, K.2
Yoda, S.3
-
20
-
-
65349166324
-
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma
-
D. Lebanony, H. Benjamin, and S. Gilad Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma J Clin Oncol 27 2009 2030 2037 10.1200/JCO.2008.19.4134
-
(2009)
J Clin Oncol
, vol.27
, pp. 2030-2037
-
-
Lebanony, D.1
Benjamin, H.2
Gilad, S.3
-
21
-
-
77953139378
-
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
-
S. Rosenwald, S. Gilad, and S. Benjamin Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin Mod Pathol 23 2010 814 823 10.1038/modpathol.2010.57
-
(2010)
Mod Pathol
, vol.23
, pp. 814-823
-
-
Rosenwald, S.1
Gilad, S.2
Benjamin, S.3
-
22
-
-
77954316346
-
MicroRNA expression differentiates between primary lung tumors and metastases to the lung
-
I. Barshack, G. Lithwick-Yanai, and A. Afek MicroRNA expression differentiates between primary lung tumors and metastases to the lung Pathol Res Pract 206 2010 578 584 10.1016/j.prp.2010.03.005
-
(2010)
Pathol Res Pract
, vol.206
, pp. 578-584
-
-
Barshack, I.1
Lithwick-Yanai, G.2
Afek, A.3
-
23
-
-
84902986190
-
MiR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung
-
34/5/2297 [pii]
-
J. Kim, N.J. Lim, S.G. Jang, H.K. Kim, and G.K. Lee miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung Anticancer Res 34 2014 2297 2302 doi:34/5/2297 [pii]
-
(2014)
Anticancer Res
, vol.34
, pp. 2297-2302
-
-
Kim, J.1
Lim, N.J.2
Jang, S.G.3
Kim, H.K.4
Lee, G.K.5
-
24
-
-
84897015133
-
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: A correlative MILD trial study
-
G. Sozzi, M. Boeri, and M. Rossi Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study J Clin Oncol 32 2014 768 773 10.1200/JCO.2013.50.4357
-
(2014)
J Clin Oncol
, vol.32
, pp. 768-773
-
-
Sozzi, G.1
Boeri, M.2
Rossi, M.3
-
25
-
-
84859295557
-
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial
-
U. Pastorino, M. Rossi, and V. Rosato Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial Eur J Cancer Prev 21 2012 308 315 10.1097/CEJ.0b013e328351e1b6
-
(2012)
Eur J Cancer Prev
, vol.21
, pp. 308-315
-
-
Pastorino, U.1
Rossi, M.2
Rosato, V.3
-
26
-
-
84977478146
-
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
-
M. Boeri, C. Verri, and D. Conte MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer Proc Natl Acad Sci U S A 108 2011 3713 3718 10.1073/pnas.1100048108
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 3713-3718
-
-
Boeri, M.1
Verri, C.2
Conte, D.3
-
27
-
-
80052027132
-
Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers
-
374-2407-11-374
-
J. Shen, Z. Liu, and N.W. Todd Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers BMC Cancer 11 2011 10.1186/1471-2407-11-374 374-2407-11-374
-
(2011)
BMC Cancer
, vol.11
-
-
Shen, J.1
Liu, Z.2
Todd, N.W.3
-
28
-
-
20544455590
-
Vinorelbine plus cisplatin vs. Observation in resected non-small-cell lung cancer
-
352/25/2589 [pii]
-
T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597 doi:352/25/2589 [pii]
-
(2005)
N Engl J Med
, vol.352
, pp. 2589-2597
-
-
Winton, T.1
Livingston, R.2
Johnson, D.3
-
29
-
-
70349304187
-
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: An analysis of the national cancer institute of canada clinical trials group JBR.10 trial
-
R.W. Jang, A. Le Maitre, and K. Ding Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the national cancer institute of canada clinical trials group JBR.10 trial J Clin Oncol 27 2009 4268 4273 10.1200/JCO.2008.20.5815
-
(2009)
J Clin Oncol
, vol.27
, pp. 4268-4273
-
-
Jang, R.W.1
Le Maitre, A.2
Ding, K.3
-
30
-
-
2342624080
-
EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
-
J.G. Paez, P.A. Janne, and J.C. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500 10.1126/science.1099314
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.G.1
Janne, P.A.2
Lee, J.C.3
-
31
-
-
45149084723
-
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations
-
L.V. Sequist, R.G. Martins, and D. Spigel First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations J Clin Oncol 26 2008 2442 2449 10.1200/JCO.2007.14.8494
-
(2008)
J Clin Oncol
, vol.26
, pp. 2442-2449
-
-
Sequist, L.V.1
Martins, R.G.2
Spigel, D.3
-
32
-
-
79959443241
-
MicroRNA expression and clinical outcome of small cell lung cancer
-
J.H. Lee, J. Voortman, and A.M. Dingemans MicroRNA expression and clinical outcome of small cell lung cancer PLoS One 6 2011 e21300 10.1371/journal.pone.0021300
-
(2011)
PLoS One
, vol.6
, pp. e21300
-
-
Lee, J.H.1
Voortman, J.2
Dingemans, A.M.3
-
33
-
-
20044395613
-
RAS is regulated by the let-7 microRNA family
-
S0092-8674(05)00088-7[pii]
-
S.M. Johnson, H. Grosshans, and J. Shingara RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647 doi:S0092-8674(05)00088-7[pii]
-
(2005)
Cell
, vol.120
, pp. 635-647
-
-
Johnson, S.M.1
Grosshans, H.2
Shingara, J.3
-
34
-
-
34247565615
-
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
-
gad.1540407 [pii]
-
Y.S. Lee, and A. Dutta The tumor suppressor microRNA let-7 represses the HMGA2 oncogene Genes Dev 21 2007 1025 1030 doi:gad.1540407 [pii]
-
(2007)
Genes Dev
, vol.21
, pp. 1025-1030
-
-
Lee, Y.S.1
Dutta, A.2
-
35
-
-
84857503465
-
Let-7 modulates acquired resistance of ovarian cancer to taxanes via IMP-1-mediated stabilization of multidrug resistance 1
-
B. Boyerinas, S.M. Park, and A.E. Murmann Let-7 modulates acquired resistance of ovarian cancer to taxanes via IMP-1-mediated stabilization of multidrug resistance 1 Int J Cancer 130 2012 1787 1797 10.1002/ijc.26190
-
(2012)
Int J Cancer
, vol.130
, pp. 1787-1797
-
-
Boyerinas, B.1
Park, S.M.2
Murmann, A.E.3
-
36
-
-
79960799901
-
Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer
-
C.J. Chang, C.C. Hsu, and C.H. Chang Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer Oncol Rep 26 2011 1003 1010 10.3892/or.2011.1360
-
(2011)
Oncol Rep
, vol.26
, pp. 1003-1010
-
-
Chang, C.J.1
Hsu, C.C.2
Chang, C.H.3
-
37
-
-
37049019490
-
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy
-
67/23/11111 [pii]
-
J.B. Weidhaas, I. Babar, and S.M. Nallur MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy Cancer Res 67 2007 11111 11116 doi:67/23/11111 [pii]
-
(2007)
Cancer Res
, vol.67
, pp. 11111-11116
-
-
Weidhaas, J.B.1
Babar, I.2
Nallur, S.M.3
-
38
-
-
69249096109
-
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
-
Y. Li, T.G. VandenBoom 2nd, and D. Kong Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells Cancer Res 69 2009 6704 6712 10.1158/0008-5472.CAN-09-1298
-
(2009)
Cancer Res
, vol.69
, pp. 6704-6712
-
-
Li, Y.1
Vandenboom, T.G.2
Kong, D.3
-
39
-
-
44849091213
-
EGFR regulation by microRNA in lung cancer: Correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
-
G.J. Weiss, L.T. Bemis, and E. Nakajima EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines Ann Oncol 19 2008 1053 1059 10.1093/annonc/mdn006
-
(2008)
Ann Oncol
, vol.19
, pp. 1053-1059
-
-
Weiss, G.J.1
Bemis, L.T.2
Nakajima, E.3
-
40
-
-
84905559842
-
MicroRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C
-
J. Hu, Y. Cheng, and Y. Li microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C Eur J Cancer 50 2014 2336 2350 10.1016/j.ejca.2014.06.005
-
(2014)
Eur J Cancer
, vol.50
, pp. 2336-2350
-
-
Hu, J.1
Cheng, Y.2
Li, Y.3
-
41
-
-
84863361375
-
MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1
-
Z.M. Shi, J. Wang, and Z. Yan MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1 PLoS One 7 2012 e32709 10.1371/journal.pone.0032709
-
(2012)
PLoS One
, vol.7
, pp. e32709
-
-
Shi, Z.M.1
Wang, J.2
Yan, Z.3
-
42
-
-
84860289964
-
Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer
-
CTMC-EPUB-20120214-010 [pii]
-
L.W. Chan, F.F. Wang, and W.C. Cho Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer Curr Top Med Chem 12 2012 920 926 doi:CTMC-EPUB-20120214-010 [pii]
-
(2012)
Curr Top Med Chem
, vol.12
, pp. 920-926
-
-
Chan, L.W.1
Wang, F.F.2
Cho, W.C.3
-
43
-
-
84866541922
-
MicroRNA-29b is involved in the src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma
-
S.I. Rothschild, M.P. Tschan, and E.A. Federzoni MicroRNA-29b is involved in the src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma Oncogene 31 2012 4221 4232 10.1038/onc.2011.578
-
(2012)
Oncogene
, vol.31
, pp. 4221-4232
-
-
Rothschild, S.I.1
Tschan, M.P.2
Federzoni, E.A.3
-
44
-
-
84938934841
-
C-myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT
-
D.W. Wu, N.Y. Hsu, and Y.C. Wang C-myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT Oncogene 0 2014 10.1038/onc.2014.152
-
(2014)
Oncogene
-
-
Wu, D.W.1
Hsu, N.Y.2
Wang, Y.C.3
-
45
-
-
35649020283
-
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
-
0707628104 [pii]
-
M. Fabbri, R. Garzon, and A. Cimmino MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 2007 15805 15810 doi:0707628104 [pii]
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 15805-15810
-
-
Fabbri, M.1
Garzon, R.2
Cimmino, A.3
-
46
-
-
80052399265
-
MicroRNA-449 in cell fate determination
-
17181 [pii]
-
M. Lize, A. Klimke, and M. Dobbelstein MicroRNA-449 in cell fate determination Cell Cycle 10 2011 2874 2882 doi:17181 [pii]
-
(2011)
Cell Cycle
, vol.10
, pp. 2874-2882
-
-
Lize, M.1
Klimke, A.2
Dobbelstein, M.3
-
47
-
-
79955913660
-
MiR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and rb-dependent manner
-
55-4598-10-55
-
N. Bandi, and E. Vassella miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and rb-dependent manner Mol Cancer 10 2011 10.1186/1476-4598-10-55 55-4598-10-55
-
(2011)
Mol Cancer
, vol.10
-
-
Bandi, N.1
Vassella, E.2
-
48
-
-
84896897599
-
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
-
N. Okada, C.P. Lin, and M.C. Ribeiro A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression Genes Dev 28 2014 438 450 10.1101/gad.233585.113
-
(2014)
Genes Dev
, vol.28
, pp. 438-450
-
-
Okada, N.1
Lin, C.P.2
Ribeiro, M.C.3
-
49
-
-
84856231030
-
MiRNA-34a is associated with docetaxel resistance in human breast cancer cells
-
L. Kastl, I. Brown, and A.C. Schofield miRNA-34a is associated with docetaxel resistance in human breast cancer cells Breast Cancer Res Treat 131 2012 445 454 10.1007/s10549-011-1424-3
-
(2012)
Breast Cancer Res Treat
, vol.131
, pp. 445-454
-
-
Kastl, L.1
Brown, I.2
Schofield, A.C.3
-
50
-
-
84883743256
-
TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.)
-
J. Zhao, P. Lammers, C.J. Torrance, and A.G. Bader TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.) Mol Ther 21 2013 1678 1686 10.1038/mt.2013.148
-
(2013)
Mol Ther
, vol.21
, pp. 1678-1686
-
-
Zhao, J.1
Lammers, P.2
Torrance, C.J.3
Bader, A.G.4
-
51
-
-
51349157982
-
The MYCN oncogene is a direct target of miR-34a
-
J.S. Wei, Y.K. Song, and S. Durinck The MYCN oncogene is a direct target of miR-34a Oncogene 27 2008 5204 5213 10.1038/onc.2008.154
-
(2008)
Oncogene
, vol.27
, pp. 5204-5213
-
-
Wei, J.S.1
Song, Y.K.2
Durinck, S.3
-
52
-
-
80052698948
-
Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells
-
K. Rai, N. Takigawa, and S. Ito Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells Mol Cancer Ther 10 2011 1720 1727 10.1158/1535-7163.MCT-11-0220
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 1720-1727
-
-
Rai, K.1
Takigawa, N.2
Ito, S.3
-
53
-
-
80655149145
-
MicroRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling
-
K.M. Lee, E.J. Choi, and I.A. Kim microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling Radiother Oncol 101 2011 171 176 10.1016/j.radonc.2011.05.050
-
(2011)
Radiother Oncol
, vol.101
, pp. 171-176
-
-
Lee, K.M.1
Choi, E.J.2
Kim, I.A.3
-
54
-
-
84860261087
-
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
-
X.G. Liu, W.Y. Zhu, and Y.Y. Huang High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer Med Oncol 29 2012 618 626 10.1007/s12032-011-9923-y
-
(2012)
Med Oncol
, vol.29
, pp. 618-626
-
-
Liu, X.G.1
Zhu, W.Y.2
Huang, Y.Y.3
-
55
-
-
84255191994
-
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer
-
M.J. Schliekelman, D.L. Gibbons, and V.M. Faca Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer Cancer Res 71 2011 7670 7682 10.1158/0008-5472.CAN-11-0964
-
(2011)
Cancer Res
, vol.71
, pp. 7670-7682
-
-
Schliekelman, M.J.1
Gibbons, D.L.2
Faca, V.M.3
-
56
-
-
84910609183
-
MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1
-
C. Gao, F.H. Peng, and L.K. Peng MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1 Neoplasma 2014 680 689 10.4149/neo-2014-083
-
(2014)
Neoplasma
, pp. 680-689
-
-
Gao, C.1
Peng, F.H.2
Peng, L.K.3
-
57
-
-
84876557012
-
Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells
-
e62334
-
T.T. Manavalan, Y. Teng, L.M. Litchfield, P. Muluhngwi, N. Al-Rayyan, and C.M. Klinge Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells PLoS One 8 2013 10.1371/journal.pone.0062334 e62334
-
(2013)
PLoS One
, vol.8
-
-
Manavalan, T.T.1
Teng, Y.2
Litchfield, L.M.3
Muluhngwi, P.4
Al-Rayyan, N.5
Klinge, C.M.6
-
58
-
-
84905489718
-
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer
-
M.A. Cortez, D. Valdecanas, and X. Zhang Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer Mol Ther 22 2014 1494 1503 10.1038/mt.2014.79
-
(2014)
Mol Ther
, vol.22
, pp. 1494-1503
-
-
Cortez, M.A.1
Valdecanas, D.2
Zhang, X.3
-
59
-
-
79959298372
-
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
-
1944-446X201106407[pii]
-
J. Wei, W. Gao, and C.J. Zhu Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer Chin J Cancer 30 2011 407 414 doi:1944-446X201106407[pii]
-
(2011)
Chin J Cancer
, vol.30
, pp. 407-414
-
-
Wei, J.1
Gao, W.2
Zhu, C.J.3
-
60
-
-
84886822565
-
MicroRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation
-
750-013-0750-1. Epub 2013 Nov 6
-
Y. Shen, D. Tang, and R. Yao microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation Med Oncol 30 2013 10.1007/s12032-013-0750-1 750-013-0750-1. Epub 2013 Nov 6
-
(2013)
Med Oncol
, vol.30
-
-
Shen, Y.1
Tang, D.2
Yao, R.3
-
61
-
-
84882726021
-
MicroRNA-21: A therapeutic target for reversing drug resistance in cancer
-
L. Hong, Y. Han, and Y. Zhang MicroRNA-21: a therapeutic target for reversing drug resistance in cancer Expert Opin Ther Targets 17 2013 1073 1080 10.1517/14728222.2013.819853
-
(2013)
Expert Opin Ther Targets
, vol.17
, pp. 1073-1080
-
-
Hong, L.1
Han, Y.2
Zhang, Y.3
-
62
-
-
84892888388
-
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
-
B. Li, S. Ren, and X. Li MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer Lung Cancer 83 2014 146 153 10.1016/j.lungcan.2013.11.003
-
(2014)
Lung Cancer
, vol.83
, pp. 146-153
-
-
Li, B.1
Ren, S.2
Li, X.3
-
63
-
-
70949104622
-
MiR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
-
M. Garofalo, G. Di Leva, and G. Romano miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation Cancer Cell 16 2009 498 509 10.1016/j.ccr.2009.10.014
-
(2009)
Cancer Cell
, vol.16
, pp. 498-509
-
-
Garofalo, M.1
Di Leva, G.2
Romano, G.3
-
64
-
-
84906283166
-
MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2
-
Z. Mei, Y. He, and J. Feng MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2 FEBS Lett 588 2014 3055 3061 10.1016/j.febslet.2014.06.020
-
(2014)
FEBS Lett
, vol.588
, pp. 3055-3061
-
-
Mei, Z.1
He, Y.2
Feng, J.3
-
65
-
-
79952195451
-
Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer
-
X.C. Wang, L.Q. Du, and L.L. Tian Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer Lung Cancer 72 2011 92 99 10.1016/j.lungcan.2010.07.014
-
(2011)
Lung Cancer
, vol.72
, pp. 92-99
-
-
Wang, X.C.1
Du, L.Q.2
Tian, L.L.3
-
66
-
-
84862877840
-
High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease
-
A. Ruzzo, F. Graziano, and B. Vincenzi High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease Oncologist 17 2012 823 829 10.1634/theoncologist.2012-0081
-
(2012)
Oncologist
, vol.17
, pp. 823-829
-
-
Ruzzo, A.1
Graziano, F.2
Vincenzi, B.3
-
67
-
-
84869195391
-
Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; Colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
-
534-2407-12-534
-
J.B. Kjersem, T. Ikdahl, and T. Guren Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab BMC Cancer 12 2012 10.1186/1471-2407-12-534 534-2407-12-534
-
(2012)
BMC Cancer
, vol.12
-
-
Kjersem, J.B.1
Ikdahl, T.2
Guren, T.3
-
68
-
-
84880594419
-
Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features
-
A. Capodanno, L. Boldrini, and A. Proietti Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features Int J Oncol 43 2013 765 774 10.3892/ijo.2013.2003
-
(2013)
Int J Oncol
, vol.43
, pp. 765-774
-
-
Capodanno, A.1
Boldrini, L.2
Proietti, A.3
-
69
-
-
67650422613
-
MiR-15a and miR-16 are implicated in cell cycle regulation in a rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer
-
N. Bandi, S. Zbinden, and M. Gugger miR-15a and miR-16 are implicated in cell cycle regulation in a rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer Cancer Res 69 2009 5553 5559 10.1158/0008-5472.CAN-08-4277
-
(2009)
Cancer Res
, vol.69
, pp. 5553-5559
-
-
Bandi, N.1
Zbinden, S.2
Gugger, M.3
-
70
-
-
70849087385
-
MiR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
-
E. Gallardo, A. Navarro, and N. Vinolas miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer Carcinogenesis 30 2009 1903 1909 10.1093/carcin/bgp219
-
(2009)
Carcinogenesis
, vol.30
, pp. 1903-1909
-
-
Gallardo, E.1
Navarro, A.2
Vinolas, N.3
-
71
-
-
79952331586
-
DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer
-
Z. Wang, Z. Chen, and Y. Gao DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer Cancer Biol Ther 11 2011 490 496 10.4161/cbt.11.5.14550
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 490-496
-
-
Wang, Z.1
Chen, Z.2
Gao, Y.3
-
72
-
-
79951938163
-
DNA methylation of tumor suppressor miRNA genes: A lesson from the miR-34 family
-
K.Y. Wong, L. Yu, and C.S. Chim DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family Epigenomics 3 2011 83 92 10.2217/epi.10.74
-
(2011)
Epigenomics
, vol.3
, pp. 83-92
-
-
Wong, K.Y.1
Yu, L.2
Chim, C.S.3
-
73
-
-
84855729906
-
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition
-
N.H. Kim, H.S. Kim, and X.Y. Li A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition J Cell Biol 195 2011 417 433 10.1083/jcb.201103097
-
(2011)
J Cell Biol
, vol.195
, pp. 417-433
-
-
Kim, N.H.1
Kim, H.S.2
Li, X.Y.3
-
74
-
-
84861496878
-
Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines
-
32/5/1603 [pii]
-
J. Balca-Silva, S. Sousa Neves, and A.C. Goncalves Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines Anticancer Res 32 2012 1603 1609 doi:32/5/1603 [pii]
-
(2012)
Anticancer Res
, vol.32
, pp. 1603-1609
-
-
Balca-Silva, J.1
Sousa Neves, S.2
Goncalves, A.C.3
-
75
-
-
57749110627
-
MicroRNAs impair MET-mediated invasive growth
-
C. Migliore, A. Petrelli, and E. Ghiso MicroRNAs impair MET-mediated invasive growth Cancer Res 68 2008 10128 10136 10.1158/0008-5472.CAN-08-2148
-
(2008)
Cancer Res
, vol.68
, pp. 10128-10136
-
-
Migliore, C.1
Petrelli, A.2
Ghiso, E.3
-
76
-
-
84903879534
-
MiR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma
-
R. Tejero, A. Navarro, and M. Campayo miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma PLoS One 9 2014 e101899 10.1371/journal.pone.0101899
-
(2014)
PLoS One
, vol.9
, pp. e101899
-
-
Tejero, R.1
Navarro, A.2
Campayo, M.3
-
77
-
-
84872674726
-
High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer
-
M. Yang, H. Shen, and C. Qiu High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer Eur J Cancer 49 2013 604 615 10.1016/j.ejca.2012.09.031
-
(2013)
Eur J Cancer
, vol.49
, pp. 604-615
-
-
Yang, M.1
Shen, H.2
Qiu, C.3
-
78
-
-
84885146774
-
Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients
-
M. Jiang, P. Zhang, and G. Hu Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients Mol Cell Biochem 383 2013 67 75 10.1007/s11010-013-1755-y
-
(2013)
Mol Cell Biochem
, vol.383
, pp. 67-75
-
-
Jiang, M.1
Zhang, P.2
Hu, G.3
-
79
-
-
84883743438
-
MiR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
-
M.T. van Jaarsveld, J. Helleman, and A.W. Boersma miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells Oncogene 32 2013 4284 4293 10.1038/onc.2012.433
-
(2013)
Oncogene
, vol.32
, pp. 4284-4293
-
-
Van Jaarsveld, M.T.1
Helleman, J.2
Boersma, A.W.3
-
80
-
-
79955499785
-
MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
-
Y. Imanaka, S. Tsuchiya, F. Sato, Y. Shimada, K. Shimizu, and G. Tsujimoto MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma J Hum Genet 56 2011 270 276 10.1038/jhg.2011.1
-
(2011)
J Hum Genet
, vol.56
, pp. 270-276
-
-
Imanaka, Y.1
Tsuchiya, S.2
Sato, F.3
Shimada, Y.4
Shimizu, K.5
Tsujimoto, G.6
-
81
-
-
84855543629
-
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
-
M. Garofalo, G. Romano, and G. Di Leva EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Nat Med 18 2011 74 82 10.1038/nm.2577
-
(2011)
Nat Med
, vol.18
, pp. 74-82
-
-
Garofalo, M.1
Romano, G.2
Di Leva, G.3
-
82
-
-
33847763576
-
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
-
67/4/1424 [pii]
-
A. Lujambio, S. Ropero, and E. Ballestar Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res 67 2007 1424 1429 doi:67/4/1424 [pii]
-
(2007)
Cancer Res
, vol.67
, pp. 1424-1429
-
-
Lujambio, A.1
Ropero, S.2
Ballestar, E.3
-
83
-
-
16244400457
-
FDA drug approval summary: Azacitidine (5-azacytidine, vidaza) for injectable suspension
-
10/3/176 [pii]
-
E. Kaminskas, A.T. Farrell, Y.C. Wang, R. Sridhara, and R. Pazdur FDA drug approval summary: Azacitidine (5-azacytidine, vidaza) for injectable suspension Oncologist 10 2005 176 182 doi:10/3/176 [pii]
-
(2005)
Oncologist
, vol.10
, pp. 176-182
-
-
Kaminskas, E.1
Farrell, A.T.2
Wang, Y.C.3
Sridhara, R.4
Pazdur, R.5
-
84
-
-
77956901498
-
The promise of microRNA replacement therapy
-
A.G. Bader, D. Brown, and M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030 10.1158/0008-5472.CAN-10-2010
-
(2010)
Cancer Res
, vol.70
, pp. 7027-7030
-
-
Bader, A.G.1
Brown, D.2
Winkler, M.3
-
85
-
-
84884815937
-
MicroRNAs as pharmacological targets in cancer
-
A. Soriano, L. Jubierre, and A. Almazan-Moga microRNAs as pharmacological targets in cancer Pharmacol Res 75 2013 3 14 10.1016/j.phrs.2013.03.006
-
(2013)
Pharmacol Res
, vol.75
, pp. 3-14
-
-
Soriano, A.1
Jubierre, L.2
Almazan-Moga, A.3
-
86
-
-
84887101163
-
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
-
H. Ling, M. Fabbri, and G.A. Calin MicroRNAs and other non-coding RNAs as targets for anticancer drug development Nat Rev Drug Discov 12 2013 847 865 10.1038/nrd4140
-
(2013)
Nat Rev Drug Discov
, vol.12
, pp. 847-865
-
-
Ling, H.1
Fabbri, M.2
Calin, G.A.3
-
87
-
-
77949658280
-
Regression of murine lung tumors by the let-7 microRNA
-
P. Trang, P.P. Medina, and J.F. Wiggins Regression of murine lung tumors by the let-7 microRNA Oncogene 29 2010 1580 1587 10.1038/onc.2009.445
-
(2010)
Oncogene
, vol.29
, pp. 1580-1587
-
-
Trang, P.1
Medina, P.P.2
Wiggins, J.F.3
-
88
-
-
41649114199
-
Suppression of non-small cell lung tumor development by the let-7 microRNA family
-
M.S. Kumar, S.J. Erkeland, and R.E. Pester Suppression of non-small cell lung tumor development by the let-7 microRNA family Proc Natl Acad Sci U S A 105 2008 3903 3908 10.1073/pnas.0712321105
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 3903-3908
-
-
Kumar, M.S.1
Erkeland, S.J.2
Pester, R.E.3
-
89
-
-
42049103216
-
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
-
5834 [pii]
-
A. Esquela-Kerscher, P. Trang, and J.F. Wiggins The let-7 microRNA reduces tumor growth in mouse models of lung cancer Cell Cycle 7 2008 759 764 doi:5834 [pii]
-
(2008)
Cell Cycle
, vol.7
, pp. 759-764
-
-
Esquela-Kerscher, A.1
Trang, P.2
Wiggins, J.F.3
-
90
-
-
79957900919
-
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
-
P. Trang, J.F. Wiggins, and C.L. Daige Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice Mol Ther 19 2011 1116 1122 10.1038/mt.2011.48
-
(2011)
Mol Ther
, vol.19
, pp. 1116-1122
-
-
Trang, P.1
Wiggins, J.F.2
Daige, C.L.3
-
91
-
-
77956269093
-
Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy
-
Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy Mol Ther 18 2010 1650 1656 10.1038/mt.2010.136
-
(2010)
Mol Ther
, vol.18
, pp. 1650-1656
-
-
Chen, Y.1
Zhu, X.2
Zhang, X.3
Liu, B.4
Huang, L.5
-
92
-
-
77955022405
-
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34
-
J.F. Wiggins, L. Ruffino, and K. Kelnar Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Res 70 2010 5923 5930 10.1158/0008-5472.CAN-10-0655
-
(2010)
Cancer Res
, vol.70
, pp. 5923-5930
-
-
Wiggins, J.F.1
Ruffino, L.2
Kelnar, K.3
-
93
-
-
84869083907
-
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
-
V.J. Craig, A. Tzankov, M. Flori, C.A. Schmid, A.G. Bader, and A. Muller Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo Leukemia 26 2012 2421 2424 10.1038/leu.2012.110
-
(2012)
Leukemia
, vol.26
, pp. 2421-2424
-
-
Craig, V.J.1
Tzankov, A.2
Flori, M.3
Schmid, C.A.4
Bader, A.G.5
Muller, A.6
-
94
-
-
84869219338
-
MiR-34 - A microRNA replacement therapy is headed to the clinic
-
A.G. Bader miR-34-a microRNA replacement therapy is headed to the clinic Front Genet 3 2012 120 10.3389/fgene.2012.00120
-
(2012)
Front Genet
, vol.3
, pp. 120
-
-
Bader, A.G.1
-
96
-
-
28444469246
-
Silencing of microRNAs in vivo with 'antagomirs'
-
nature04303 [pii]
-
J. Krutzfeldt, N. Rajewsky, and R. Braich Silencing of microRNAs in vivo with 'antagomirs' Nature 438 2005 685 689 doi:nature04303 [pii]
-
(2005)
Nature
, vol.438
, pp. 685-689
-
-
Krutzfeldt, J.1
Rajewsky, N.2
Braich, R.3
-
97
-
-
83255194160
-
Chemical modification and design of anti-miRNA oligonucleotides
-
K.A. Lennox, and M.A. Behlke Chemical modification and design of anti-miRNA oligonucleotides Gene Ther 18 2011 1111 1120 10.1038/gt.2011.100
-
(2011)
Gene Ther
, vol.18
, pp. 1111-1120
-
-
Lennox, K.A.1
Behlke, M.A.2
-
98
-
-
84884252518
-
Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier
-
K.A. Lennox, R. Owczarzy, D.M. Thomas, J.A. Walder, and M.A. Behlke Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier Mol Ther Nucleic Acids 2 2013 e117 10.1038/mtna.2013.46
-
(2013)
Mol Ther Nucleic Acids
, vol.2
, pp. e117
-
-
Lennox, K.A.1
Owczarzy, R.2
Thomas, D.M.3
Walder, J.A.4
Behlke, M.A.5
-
99
-
-
33646027887
-
LNA-modified oligonucleotides mediate specific inhibition of microRNA function
-
S0378-1119(06)00023-0[pii]
-
U.A. Orom, S. Kauppinen, and A.H. Lund LNA-modified oligonucleotides mediate specific inhibition of microRNA function Gene 372 2006 137 141 doi:S0378-1119(06)00023-0[pii]
-
(2006)
Gene
, vol.372
, pp. 137-141
-
-
Orom, U.A.1
Kauppinen, S.2
Lund, A.H.3
-
100
-
-
34548316982
-
MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells
-
nmeth1079 [pii]
-
M.S. Ebert, J.R. Neilson, and P.A. Sharp MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nat Methods 4 2007 721 726 doi:nmeth1079 [pii]
-
(2007)
Nat Methods
, vol.4
, pp. 721-726
-
-
Ebert, M.S.1
Neilson, J.R.2
Sharp, P.A.3
-
101
-
-
84891765459
-
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
-
L.F. Gebert, M.A. Rebhan, S.E. Crivelli, R. Denzler, M. Stoffel, and J. Hall Miravirsen (SPC3649) can inhibit the biogenesis of miR-122 Nucleic Acids Res 42 2014 609 621 10.1093/nar/gkt852
-
(2014)
Nucleic Acids Res
, vol.42
, pp. 609-621
-
-
Gebert, L.F.1
Rebhan, M.A.2
Crivelli, S.E.3
Denzler, R.4
Stoffel, M.5
Hall, J.6
-
102
-
-
84877258007
-
Treatment of HCV infection by targeting microRNA
-
H.L. Janssen, H.W. Reesink, and E.J. Lawitz Treatment of HCV infection by targeting microRNA N Engl J Med 368 2013 1685 1694 10.1056/NEJMoa1209026
-
(2013)
N Engl J Med
, vol.368
, pp. 1685-1694
-
-
Janssen, H.L.1
Reesink, H.W.2
Lawitz, E.J.3
-
103
-
-
74249112787
-
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
-
R.E. Lanford, E.S. Hildebrandt-Eriksen, and A. Petri Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201 10.1126/science.1178178
-
(2010)
Science
, vol.327
, pp. 198-201
-
-
Lanford, R.E.1
Hildebrandt-Eriksen, E.S.2
Petri, A.3
-
104
-
-
84881670319
-
Clinical evaluation of microRNA expression profiling in non small cell lung cancer
-
A. Markou, I. Sourvinou, P.A. Vorkas, G.M. Yousef, and E. Lianidou Clinical evaluation of microRNA expression profiling in non small cell lung cancer Lung Cancer 81 2013 388 396 10.1016/j.lungcan.2013.05.007
-
(2013)
Lung Cancer
, vol.81
, pp. 388-396
-
-
Markou, A.1
Sourvinou, I.2
Vorkas, P.A.3
Yousef, G.M.4
Lianidou, E.5
-
105
-
-
84878757129
-
Plasma processing conditions substantially influence circulating microRNA biomarker levels
-
H.H. Cheng, H.S. Yi, and Y. Kim Plasma processing conditions substantially influence circulating microRNA biomarker levels PLoS One 8 2013 e64795 10.1371/journal.pone.0064795
-
(2013)
PLoS One
, vol.8
, pp. e64795
-
-
Cheng, H.H.1
Yi, H.S.2
Kim, Y.3
-
106
-
-
79953301730
-
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
-
K.C. Vickers, B.T. Palmisano, B.M. Shoucri, R.D. Shamburek, and A.T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat Cell Biol 13 2011 423 433 10.1038/ncb2210
-
(2011)
Nat Cell Biol
, vol.13
, pp. 423-433
-
-
Vickers, K.C.1
Palmisano, B.T.2
Shoucri, B.M.3
Shamburek, R.D.4
Remaley, A.T.5
-
107
-
-
34249302620
-
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
-
ncb1596 [pii]
-
H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659 doi:ncb1596 [pii]
-
(2007)
Nat Cell Biol
, vol.9
, pp. 654-659
-
-
Valadi, H.1
Ekstrom, K.2
Bossios, A.3
Sjostrand, M.4
Lee, J.J.5
Lotvall, J.O.6
-
108
-
-
79953202200
-
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
-
J.D. Arroyo, J.R. Chevillet, and E.M. Kroh Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc Natl Acad Sci U S A 108 2011 5003 5008 10.1073/pnas.1019055108
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 5003-5008
-
-
Arroyo, J.D.1
Chevillet, J.R.2
Kroh, E.M.3
-
109
-
-
85016304525
-
Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood
-
10.3402/jev.v3.23743.eCollection 2014
-
L. Cheng, R.A. Sharples, B.J. Scicluna, and A.F. Hill Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood J Extracell Vesicles 3 2014 10.3402/jev.v3.23743 10.3402/jev.v3.23743.eCollection 2014
-
(2014)
J Extracell Vesicles
, vol.3
-
-
Cheng, L.1
Sharples, R.A.2
Scicluna, B.J.3
Hill, A.F.4
-
110
-
-
57049103401
-
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
-
J. Skog, T. Wurdinger, and S. van Rijn Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 2008 1470 1476 10.1038/ncb1800
-
(2008)
Nat Cell Biol
, vol.10
, pp. 1470-1476
-
-
Skog, J.1
Wurdinger, T.2
Van Rijn, S.3
-
111
-
-
62549125455
-
Exosomal microRNA: A diagnostic marker for lung cancer
-
G. Rabinowits, C. Gercel-Taylor, J.M. Day, D.D. Taylor, and G.H. Kloecker Exosomal microRNA: a diagnostic marker for lung cancer Clin Lung Cancer 10 2009 42 46 10.3816/CLC.2009.n.006
-
(2009)
Clin Lung Cancer
, vol.10
, pp. 42-46
-
-
Rabinowits, G.1
Gercel-Taylor, C.2
Day, J.M.3
Taylor, D.D.4
Kloecker, G.H.5
-
112
-
-
79960960417
-
Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche
-
C. Grange, M. Tapparo, and F. Collino Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche Cancer Res 71 2011 5346 5356 10.1158/0008-5472.CAN-11-0241
-
(2011)
Cancer Res
, vol.71
, pp. 5346-5356
-
-
Grange, C.1
Tapparo, M.2
Collino, F.3
-
113
-
-
84904393091
-
Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer
-
M. Rodriguez, J. Silva, and A. Lopez-Alfonso Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer Genes Chromosom Cancer 53 2014 713 724 10.1002/gcc.22181
-
(2014)
Genes Chromosom Cancer
, vol.53
, pp. 713-724
-
-
Rodriguez, M.1
Silva, J.2
Lopez-Alfonso, A.3
-
114
-
-
84892702249
-
Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis
-
T. Yamashita, H. Kamada, and S. Kanasaki Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis Pharmazie 68 2013 969 973
-
(2013)
Pharmazie
, vol.68
, pp. 969-973
-
-
Yamashita, T.1
Kamada, H.2
Kanasaki, S.3
-
115
-
-
33746548361
-
Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes
-
26/514 [pii]
-
S. Hao, Z. Ye, and F. Li Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes Exp Oncol 28 2006 126 131 doi:26/514 [pii]
-
(2006)
Exp Oncol
, vol.28
, pp. 126-131
-
-
Hao, S.1
Ye, Z.2
Li, F.3
|